Abstract: Disclosed are compositions comprising an antisense oligonucleotide and a non-ionic, low-osmolar contrast agent. Also disclosed are methods of delivering an antisense oligonucleotide to a target sire comprising incorporating the antisense oligonucleotide into a composition comprising a non-ionic, low-osmolar contrast agent. Also disclosed are methods of treating a neurodegenerative disease comprising administering one or more of the compositions disclosed herein.
Type:
Grant
Filed:
December 6, 2012
Date of Patent:
August 8, 2017
Assignee:
Ohio State Innovation Foundation and Research Institute at Nationwide Children's Hospital
Inventors:
Arthur Burghes, Paul Porensky, Brian Kaspar